December 1, 2016 - By Dolores Ford · 0 Comments
The stock of DS Healthcare Group Incorporated (NASDAQ:DSKX) registered an increase of 0.04% in short interest. DSKX’s total short interest was 487,300 shares in December as published by FINRA. Its up 0.04% from 487,100 shares, reported previously. The stock last traded at $0.66 per share. It is down 0.00% since April 28, 2016 and is . It has underperformed by 5.93% the S&P500.
DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The company has a market cap of $11.78 million. The Firm develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It currently has negative earnings. It develops technologies and products for hair care and personal care needs.
Insitutional Activity: The institutional sentiment increased to 3 in Q2 2016. Its up 1.00, from 2 in 2016Q1. The ratio increased, as 1 funds sold all DS Healthcare Group Inc shares owned while 1 reduced positions. 2 funds bought stakes while 2 increased positions. They now own 1.90 million shares or 0.38% less from 1.91 million shares in 2016Q1.
Barclays Public Limited Co accumulated 3 shares or 0% of the stock. Blackrock Fund Advsr holds 0% or 33,138 shares in its portfolio. Northern Tru Corporation holds 0% or 17,419 shares in its portfolio. Geode Cap Mgmt last reported 52,113 shares in the company. Raymond James Assoc reported 47,976 shares or 0% of all its holdings. Moreover, Morgan Stanley has 0% invested in DS Healthcare Group Inc (NASDAQ:DSKX) for 39 shares. Frigate Ventures L P owns 1.19M shares or 0.11% of their US portfolio. Moreover, Susquehanna Gru Ltd Liability Partnership has 0% invested in DS Healthcare Group Inc (NASDAQ:DSKX) for 62,340 shares. National Bank & Trust Of America De last reported 504 shares in the company. Blackrock Management holds 0% or 2,078 shares in its portfolio. Deutsche Bancshares Ag has invested 0% of its portfolio in DS Healthcare Group Inc (NASDAQ:DSKX). Blackrock Institutional Tru Na holds 0% or 140,008 shares in its portfolio. Tower Limited Liability Company (Trc) has 0% invested in the company for 350 shares. Vanguard Grp has 355,291 shares for 0% of their US portfolio.
Out of 2 analysts covering DS Healthcare Group (NASDAQ:DSKX), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. DS Healthcare Group has been the topic of 3 analyst reports since October 1, 2015 according to StockzIntelligence Inc. H.C. Wainwright initiated DS Healthcare Group Inc (NASDAQ:DSKX) rating on Thursday, October 1. H.C. Wainwright has “Buy” rating and $6 price target. Rodman & Renshaw maintained DS Healthcare Group Inc (NASDAQ:DSKX) on Thursday, March 31 with “Buy” rating. The firm has “Buy” rating by Rodman & Renshaw given on Friday, October 2.
DS Healthcare Group, Inc., doing business as DS Laboratories, incorporated on January 26, 2007, is a personal care, product development and marketing company. The Firm develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. The Company’s technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells.
More notable recent DS Healthcare Group Inc (NASDAQ:DSKX) news were published by: Businesswire.com which released: “Robbins Arroyo LLP: DS Healthcare Group, Inc. (DSKX) Misled Shareholders …” on March 30, 2016, also Globenewswire.com with their article: “Ds Healthcare Group Comments on Recent Developments” published on March 29, 2016, Businesswire.com published: “PhotoMedex to Sell Consumer and Professional Businesses to DS Healthcare Group” on February 22, 2016. More interesting news about DS Healthcare Group Inc (NASDAQ:DSKX) were released by: Globenewswire.com and their article: “DS Healthcare Group Issues Letter to Shareholders” published on November 14, 2014 as well as Globenewswire.com‘s news article titled: “Lawsuit for Investors in DS Healthcare Group Inc (NASDAQ:DSKX) shares …” with publication date: April 20, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Dolores Ford